AI & Technology
AI drug discovery: Focusing on what matters most
- Source:
- McKinsey & Company
- Published:
- 21 September 2026
McKinsey & Company highlights that AI is accelerating drug discovery, but investment has concentrated in molecule design, the stage with the best data and clearest tools. The industry’s real constraint is identifying and validating the right disease mechanism.
Summary by TAWAJOH TECH. Read the original for the full text.
Read original source (opens in a new tab)
TAWAJOH TECH